Dallah Healthcare Co. · TADAWUL:4004
Dallah Healthcare — H1 2024 Earnings Presentation
25 slides from Dallah Healthcare's earnings presentation, 2024
Slide 1: Dallah Healthcare Co. H1 2024
Dallah Healthcare Co. H1 - 2024
Slide 2: DHC's mission and vision guided by core values
DHC’s mission and vision … … guided by core values Mission Values To deliver excellent healthcare services Care and respect for our patients, which are consistent with our values and their needs and our society with the expectation of our patients, society, and partners Commitment to professional et
Slide 3: Dallah Healthcare Company offers an attractive investment opportunity
DHC has long been established in KSA and has shown year-on-year growth DHC has a strong product portfolio, consistently growing to address the evolving needs of patients Dallah Healthcare Company offers an DHC has numerous certifications positioning it at the forefront in terms of service excellence
Slide 4: Dallah Health Company History
Dallah Hospital- 1987 Al Nakheel Dallah Pharma 2002 Dallah Ob-gyne 2007 * Al Salam and Al Ahsa deal is subject to CMA approval 2012 DHC listing Dallah Pediatrics 2013 Jordanian Pharmaceuticals Co. Afyaa Al Nakheel 2014 and DMRF North clinics 2015 quite rapidly both organically and inorganically Dall
Slide 5: DHC owns and directly operates five categories of companies
Dallah Health Company Portfolio Today, DHC owns and directly operates five categories of companies while also engaging in active management of portfolio investments Owned & operated by DHC Portfolio investments (ownership share, %) Hospitals Clinics Dr. MRF Hospital Fully equipped private hospital,
Slide 6: With +2,560 beds, DHC aims to further expand to meet future demand
Dallah Health Company Portfolio With +2,560 beds, DHC aims to further expand to meet future demand Combined current capacity at +2,560 beds across DHC's operational entities and investments Companies owned & operated by 540 300 2 1 475 beds beds Location City beds DHC Portfolio investments Portfolio
Slide 7: Future Projects
1 Dallah Al Aarid Hospital: • Land: 45,000 sqm • Built-up area: 87,300 sqm • 250 Beds • SAR 690 M (Executing the construction, electromechanical and finishing works) Future 2 Dallah Al Nakheel Land: Projects • DHC, Dallah Real Estate, Aljazira Capital, and Tatweer signed MoU to establish a private r
Slide 8: DHC's presence over the Kingdom of Saudi Arabia
Dallah Health Company Portfolio Al Khobar �اﻟﺨ ب Al Hofuf اﻟﻬﻔﻮف DHC's presence over the Kingdom of Saudi Arabia 7
Slide 9: Array of medical services offered by DHC hospitals
Dallah Health Company Portfolio The array of medical services offered by DHC hospitals extends across various specialties, complemented by supplementary support services 25+ Medical and Nursing Services 4+ key Ancillary Services Medical services under the following therapy areas: Supplementary suppo
Slide 10: DHC's hospitals have demonstrated consistent patient volume growth
Dallah Health Company Portfolio Over the past 5 years, DHC's hospitals have demonstrated consistent patient volume growth Patient volume (in 000s) CAGR 23% 2,679 1% 2,252 1,800 1,309 1,327 1,166 968 2019 2020 2021 2022 2023 H1-23 H1-24 * MMC and KHCC was added in 2021 9
Slide 11: Dallah Pharma serves as another strong operational asset within DHC
Dallah Health Company Portfolio Dallah Pharma serves as another strong operational asset within DHC, with a presence across various locations in KSA and supported by renowned partners … with a strong product portfolio … supported by renowned and well- spanning across 6 categories … established partn
Slide 12: Certifications, accreditations, and awards for service excellence and patient safety
Dallah Health Company Accreditations When addressing service excellence and patient safety, DHC has acquired several well-regarded certifications, accreditations, and awards One of the first hospitals in Dallah Hospital laboratory Dallah Hospitals catering Saudi Arabia awarded JCI certified by the C
Slide 13: DHC's future growth is supported by its well-defined 5-year strategy
Dallah Health Company Growth Strategy & Leadership DHC's future growth is supported by its well-defined 5-year strategy anchored around a coherent direction for the diversified portfolio Deep-dive included in the next slides Operating companies Investments Become a one-stop shop for VIP/A privately
Slide 14: Becoming a 'one-stop high-end' service provider
Dallah Health Company Growth Strategy & Leadership To become a 'one-stop high-end' service provider, DHC will selectively specialize as well as expand into clinics, telemedicine, post-acute care and homecare Value One-stop-shop high-end provider First point of contact from the cradle to the grave Pr
Slide 15: Key consolidated financial metrics H1-23 vs H1-24
Dallah Health Company Financial Performance Regarding its financial performance, DHC has experienced a strong financial performance between H1-23 and H1-24 Key consolidated financial metrics (SAR M) H1-23 H1-24 Revenues 1,387 11.7% 1,549 EBITDA 301 19.6% 360 EBIT 241 20.5% 290 Net Profit 163 52% 248
Slide 16: Financial results over 5 years (1/5): Revenues
Dallah Health Company Financial Performance The trend of strong financial growth extends since 2021 and is supported by DHC's financial results over 5 years (1/5) Revenues (SAR M) 2,943 CAGR 12% 24% 2,488 2,105 1,549 1,387 1,318 1,252 2019 2020 2021 2022 2023 H1-23 H1-24 15
Slide 17: Financial results over 5 years (2/5): Gross Profit
Dallah Health Company Financial Performance The trend of strong financial growth extends since 2021 and is supported by DHC's financial results over 5 years (2/5) Gross Profit (SAR M) CAGR 140025% 18% 1200 40% 38% 40% 36% 36% 36% 37% 1200 36% 34% 1000 35% 35% 1000 1,079 30% 30% 800 895 25% 800 25% 7
Slide 18: Financial results over 5 years (2/5): Gross Profit
Dallah Health Company Financial Performance The trend of strong financial growth extends since 2021 and is supported by DHC's financial results over 5 years (2/5) Gross Profit (SAR M) CAGR 140025% 18% 1200 40% 38% 40% 36% 36% 36% 37% 1200 36% 34% 1000 35% 35% 1000 1,079 30% 30% 800 895 25% 800 25% 7
Slide 19: Financial results over 5 years (3/5): EBIT
Dallah Health Company Financial Performance The trend of strong financial growth extends since 2021 and is supported by DHC's financial results over 5 years (3/5) 900 30% 800 30% EBIT (SAR M) 800CAGR 700 20% 30% 25% 25% 700 600 600 20% 19% 20% 17% 500 17% 17% 17% 500 14% 504 15% 400 15% 400 422 11%
Slide 20: Financial results over 5 years (4/5): EBITDA
Dallah Health Company Financial Performance The trend of financial growth extends since 2021 and is supported by DHC's financial results over 5 years (4/5) EBITDA (SAR M) 900 30% 800 30% CAGR 20% 800 24% 700 25% 25% 23% 700 22% 21% 21% 22% 21% 600 600 630 20% 20% 18% 500 500 514 15% 400 15% 400 449
Slide 21: Financial results over 5 years (5/5): Net Profit
35% 1000 30% Dallah Health Company Financial Performance 800 The trend of strong financial growth extends since 2021 30% and is supported by DHC's financial results over 5 years (5/5) 25% 800 25% Net Profit (SAR M) 600 CAGR 20% 52% 27% 600 20% 16% 15% 400 15% 13% 13% 12% 400 12% 12% 385 10% 10% 8% 2
Slide 22: Debt-to-EBITDA ratio decreasing through informed capital allocation
Dallah Health Company Financial Performance As for its debt-to-EBITDA ratio, DHC is pursuing YoY decreases through more informed capital allocation strategies during its expansion Debt-to-EBITDA (M SAR) 3.8x 6.5x 4.2x 3.7x 3x 3.1x 2.5x 1,935 1,895 1,873 1,867 1,783 1,515 1,021 630 514 449 360 269 30
Slide 23: Q1-25 is the second highest quarter ever in terms of revenues
Dallah Health Company Financial Performance Q1-25 is the second highest quarter ever in terms of revenues Revenues (SAR M) 848 833 806 784 809 750 765 717 670 Q1-23 Q2-23 Q3-23 Q4-23 Q1-24 Q2-24 Q3-24 Q4-24 Q1-25 22
Slide 24: DHC achieved a high return on equity in the past 5 years
Dallah Health Company Financial Performance DHC achieved a high return on equity in the past 5 years, averaging between 9% to 14% Return on Equity (SAR M) 56% 14% 14% 13% 12% 9% 9% 7% 2019 2020 2021 2022 2023 H1-23 H1-24 23
Slide 25: Thank you
Thank you